Bacillus anthracis lethal toxin consists of the protective antigen (PA) and the metalloprotease lethal factor (LF). During cellular uptake PA forms pores in membranes of endosomes, and unfolded LF translocates through the pores into the cytosol. We have investigated whether host cell chaperones facilitate translocation of LF and the fusion protein LFNDTA. LFN mediates uptake of LFNDTA into the cytosol, where DTA, the catalytic domain of diphtheria toxin, ADP-ribosylates elongation factor-2, allowing for detection of small amounts of translocated LFNDTA. Cyclosporin A, which inhibits peptidyl-prolyl cis/trans isomerase activity of cyclophilins, and radicicol, which inhibits Hsp90 activity, prevented uptake of LFNDTA into the cytosol of CHO-K1 cells and protected cells from intoxication by LFNDTA/PA. Both inhibitors, as well as an antibody against cyclophilin A blocked the release of active LFNDTA from endosomal vesicles into the cytosol in vitro. In contrast, the inhibitors did not inhibit cellular uptake of LF. In vitro, cyclophilin A and Hsp90 bound to LFNDTA and DTA but not to LF, implying that DTA determines this interaction. In conclusion, cyclophilin A and Hsp90 facilitate translocation of LF NDTA, but not of LF, across endosomal membranes, and thus they function selectively in promoting translocation of certain proteins, but not of others.
Introduction
The anthrax toxin produced by B. anthracis, consists of three different protein components: lethal factor (LF), a 90 kDa metalloprotease that cleaves MAP kinase kinases (Duesbery et al., 1998; Vitale et al., 1998; Tonello and Montecucco, 2009) ; oedema factor (EF), an 89 kDa adenylyl cyclase (Leppla, 1982; 1991) ; and protective antigen (PA), an 83 kDa binding and translocation component. PA mediates the transport of LF and EF into the cytosol of target cells, where they exhibit their activities [for review see (Young and Collier, 2007; Collier, 2009) ].c mi_1539 359.. 373 The first step in toxin uptake is binding of PA to one of the two anthrax toxin receptors on the cell surface, TEM8 (tumour endothelial marker 8, alias ANTXR1) and CMG2 (capillary morphogenesis 2, alias ANTXR2) (Young and Collier, 2007) . Cell-bound PA becomes proteolytically activated and the resulting biologically active fragment, PA63, forms ring-shaped oligomers (heptamers and octamers), which bind LF and EF (Young and Collier, 2007) . Subsequently, the receptor-bound toxin complexes are internalized by actin-and clathrin-dependent endocytosis and delivered to acidic endosomes (Friedlander, 1986; Abrami et al., 2003; 2010; Zornetta et al., 2010) . There, the acidic condition triggers conformational changes of the PA63 oligomers and their conversion into membrane-spanning pores (Blaustein et al., 1989; Miller et al., 1999) , which serve as translocases for LF and EF. The pH gradient across the endosomal membrane has been proposed to be the major driving force for translocation of LF and EF through the pores to the cytosol (Wesche et al., 1998; Krantz et al., 2006) . The PA63 pore is a mushroom-shaped structure with a membrane-spanning b-barrel stem that is~10 nm long and~1.5 nm wide (Benson et al., 1998; Nassi et al., 2002) and thus necessitates unfolding of LF and EF to pass through the narrow pores (Krantz et al., 2004) .
Unfolding of LF and EF is promoted by the acidic pH of the endosomal lumen, which destabilizes the proteins and causes their N-terminal domains LFN and EFN, respectively, to become molten globules (Krantz et al., 2004) . Moreover, the pH gradient across the endosomal membrane is believed to promote directionally biased diffusion (ratcheting) of LF and EF through the pore, according to a Brownian ratchet model of toxin translocation (Krantz et al., 2005) . In the oligomeric PA63 pore, the phenylalanine-427 residues form the so-called F-clamp, which has a chaperone-like function and catalyses translocation of unfolded proteins through the pore (Krantz et al., 2005) .
It was demonstrated recently that delivery of LFNDTA from the lumen of acidified endosomes to the cytosol requires cytosolic host cell factors (Tamayo et al., 2008) . The N-terminal domain of LF (LFN) interacts with PA and mediates internalization and membrane translocation of LFNDTA. The catalytic domain of diphtheria toxin (DTA) harbours ADP-ribosyltransferase activity and allows sensitive detection of translocated LFNDTA. Therefore, LFNDTA is an established tool to study membrane translocation via the PA pore [see (Collier, 2009) for review]. Membrane translocation of LFNDTA from endosomal vesicles is facilitated by the COPI coatomer complex in vitro and components of the COPI coatomer complex interact with the LFN domain (Tamayo et al., 2008) .
In the present report, we have used LFNDTA to address whether host cell chaperones and peptidyl prolyl cis/trans isomerases (PPIases), in particular cyclophilins (Cyps), are involved in membrane translocation via the PA pore. Cyps accelerate the cis/trans isomerization of proline-peptide bonds, often a rate-limiting step of protein folding (Fischer et al., 1989; Bang and Fischer, 1991; Schmid, 1993; Schmid et al., 1993) . We have found that cyclosporin A (CsA), which inhibits the PPIase activity of Cyps (Handschumacher et al., 1984) , and radicicol (Rad), an inhibitor of Hsp90 acitivity [for recent review see (Wandinger et al., 2008) ], protected CHO-K1 cells from intoxication by LF NDTA/PA, but not by PA/LF. Moreover, both compounds inhibited the PA-mediated release of active LFNDTA, but not of LF, from purified endosomal vesicles to the cytosol in vitro, and we identified CypA as the essential Cyp involved in this process. In vitro, Hsp90 as well as CypA specifically bound to LFNDTA and DTA but not to LF. In conclusion, our data show that both host cell factors facilitate the PA-mediated translocation/refolding of LFNDTA but not of LF. The results support the hypothesis that among bacterial toxins the interaction with Hsp90/CypA during intracellular membrane translocation of the catalytic domains might be selective for bacterial ADPribosyltransferases.
Results

CsA protects cells from intoxication by LF NDTA/PA
In this study, we first investigated whether Cyps are involved in cellular uptake of LFNDTA, which consists of the N-terminal part of LF (LFN, aa 1-263) and the catalytic domain of diphtheria toxin (DTA). DTA ADPribosylates mammalian elongation factor 2 (EF-2) and inhibits protein biosynthesis in intoxicated cells. Thus, cellular uptake of LFNDTA can be easily followed by monitoring protein synthesis levels. CHO-K1 cells were incubated for 4 h with LFNDTA + PA in the absence or presence of CsA, an inhibitor of the PPIase activity of Cyps. DTA-mediated inhibition of protein synthesis was then monitored by measuring the incorporation of ]-leucine was determined by scintillation counting. As expected, treatment of cells with LFNDTA + PA strongly inhibited protein synthesis, indicating that EF-2 was inactivated by the toxin (Fig. 1) . Addition of CsA increased protein synthesis levels in PA/LFNDTA treated cells by~4-fold (Fig. 1 ), while CsA protects CHO-K1 cells from cytotoxic effects caused by LFNDTA. CHO-K1 cells were pretreated for 30 min at 37°C in the presence or absence of 1 M CsA. Subsequently, PA83 (10 nM) and LFNDTA (10 nM) were added to the cells. As a control, buffer alone was applied (denoted: con). Cells were incubated for an additional 4 h before adding [ ]-leucine using a scintillation counter. The readout is counts per minute (CPM). The values shown are the average of three trials and the error bars represent standard error of the mean. Significance was tested by using the student's t-test (**P < 0.005). treatment with CsA alone (in the absence of toxin) had no effect on protein synthesis (data not shown). These results suggest that CsA alleviates the toxin-mediated block of protein synthesis by preventing the inactivation of EF-2 by LFNDTA.
Next, we directly investigated the effect of CsA on the ADP-ribosylation status of EF-2 in CHO-K1 cells after treatment with LFNDTA + PA. Cells were pretreated with or without CsA for 30 min, after which time buffer alone or buffer containing LFNDTA + PA was added, and the cells were further incubated at 37°C. As a positive control, before the addition of LFNDTA + PA, cells were treated with bafilomycin A1, which blocks PA-mediated translocation of LFNDTA by preventing endosomal acidification. After 1 and 3 h, cells were lysed and the ADP-ribosylation status of EF-2 was analysed by post-ADP-ribosylation with biotin-NAD + ( Fig. 2A , quantification of the signals is shown in the lower panel). In cells treated with LFNDTA + PA without inhibitor, there was a weak signal of biotin-ADP-ribosylated EF-2 after 3 h, indicating that at this time point most of the EF-2 had been ADP-ribosylated by LFNDTA in the intact cells. In Fig. 2 . CsA prevents ADP-ribosylation of EF-2 in CHO-K1 cells treated with PA63 plus LFNDTA. A. Effects of Baf A1 and CsA on the LFNDTA-mediated ADP-ribosylation of EF-2 in toxin-treated CHO cells. Cells were pretreated for 30 min with Baf A1 (100 nM) or CsA (10 mM) and PA63 (1.6 nM) + LFNDTA (1.9 nM) were added to the cells. For control, cells were left untreated (con). After 1 and 3 h of incubation, cells were lysed and the ADP-ribosylation status of EF-2 from these cells was analysed by post-ADP-ribosylation. Intensity of the ADP-ribosylated EF-2 was quantified by densitometry. B. Time course of the ADP-ribosylation of EF-2 by LFNDTA in CHO-K1 cells in the presence and absence of CsA. CHO-K1 cells were incubated for 30 min at 37°C in the absence or presence of CsA (20 mM) and subsequently PA63 (1.2 nM) + LFNDTA (1.4 nM) were added. Cells were incubated for the indicated periods, lysed and the ADP-ribosylation status of EF-2 from these cells was analysed (upper panel). Equal amounts of protein were confirmed by anti-b-actin-immunoblot (lower panel). Intensity of the ADP-ribosylated EF-2 was quantified by densitometry (black bars: PA + LFNDTA; grey bars: CsA + PA + LFNDTA). 
CsA prevents the uptake of LFNDTA into the cytosol of toxin-treated cells
In the presence of CsA, less LFNDTA protein was detected in the cytosolic fractions of LFNDTA/PA-treated CHO-K1 cells. Cells were pretreated for 30 min with or without CsA, and then biotin-LFNDTA and PA were added. After 1.5 h of incubation, the cytosolic fractions of these cells were obtained by digitonin extraction as described recently (Kaiser et al., 2009) and analysed for the presence of biotin-LFNDTA. The successful separation of cytosolic fractions from the remaining extracted cells was confirmed by immunoblot analysis with antibodies against early endosomal antigen 1 (EEA1), a marker protein for early endosomes, and MEK1, a cytosolic marker protein (Fig. 3A) . Most importantly, no EEA1 was detectable in the cytosolic fractions, indicating that there was no contamination by early endosomes, which might contain LFNDTA. Figure 3B shows the amount of biotin-LFNDTA in the cytosolic fractions in the presence and absence of CsA. Quantification of these signals revealed that there was significantly less LFNDTA protein in the cytosol when cells were pretreated with CsA (Fig. 3B ). These data imply that Cyps play a role in the uptake of LFNDTA into the cytosol of mammalian target cells. We investigated at which individual step CsA interferes with cellular uptake of LFNDTA and found that CsA did not prevent the PA-mediated binding of LFNDTA to the cell surface, as detected by Western blot analysis of Thereafter, cells were washed and incubated with digitonin buffer (20 mg ml -1 digitonin in PBS) for 5 min at 25°C followed by 30 min incubation on ice to extract the cytosol. A. Characterization of the cytosolic fractions from digitonin extraction by immunoblot analysis. Cytosolic fractions were blotted and probed with antibody against EEA1 to exclude contamination by early endosomes (upper panel). Extracted cells were taken for control. In parallel, cytosols were analysed with an antibody against the cytosolic marker protein MEK1 (lower panel). B. Detection of biotin-LFNDTA from the cytosolic fractions with streptavidin-peroxidase. Intensity of the biotin-LFNDTA signals was quantified by densitometry and is given as mean Ϯ SD (n = 3); Significance was tested against the cells without CsA by using the student's t-test (*P < 0.05).
cell bound LFNDTA (not shown). Therefore, we focused on the effect of CsA on membrane translocation of the toxin.
CsA has an inhibitory effect on the in vitro translocation of LFNDTA from enriched endosomal vesicles
We tested the effect of CsA on in vitro translocation of LFNDTA from the lumen of enriched endosomes into the cytosol. Endosomes were preloaded with LFNDTA as described earlier by Tamayo et al. (Tamayo et al., 2008) . Briefly, CHO cells were incubated with LFNDTA + PA in the presence of bafilomycin A1, cells were lysed, and endosomal vesicles were purified by discontinuous sucrose density gradient ultracentrifugation. The partially purified endosomal vesicles were used for in vitro translocation studies. Translocation of LFNDTA across the membranes of the endosomal vesicles was induced by addition of freshly prepared CHO cytosol and ATP. The assay mixture, which contained also biotin-NAD + , was incubated for 30 min at 37°C and the ADPribosyltransferase activity of translocated LFNDTA was detected by monitoring the ADP-ribosylation, i.e. biotinylation, of EF-2 in the cytosolic supernatant (Fig. 4A) . We confirmed by anti-MEK1 immunoblot analysis that the analysed samples contained comparable amounts of protein ( Fig. 4A, lower panel) .
To test the influence of CsA on translocation of LFNDTA from endosomal vesicles, cytosol was preincubated for 30 min at 37°C with 20 mM CsA before application to the vesicles. Thereafter, the endosomal vesicles were pelleted by ultracentrifugation. The cytosolic supernatant was subjected to SDS-PAGE, blotted and the biotin-labelled EF-2 was detected and quantified ( Fig. 4B ). The pretreatment of the cytosol with CsA (20 mM) resulted in significantly less ADPribosylation of EF-2. Importantly, equal protein loading was confirmed by MEK1 antibody (see Fig. 4B , lower panel). When higher final concentrations of CsA (60 mM) were used in this assay, only negligible ADP-ribosylation of EF-2 was detected. However, 60 mM of CsA had a moderate inhibitory effect on the enzyme activity of LF NDTA in vitro and therefore we did not use such concentrations of CsA in our experiments. These results indicate that there was less active LFNDTA in CsAtreated cytosol, implying that Cyps facilitate the transport of active LFNDTA from LFNDTA/PA-loaded endosomal vesicles into the cytosolic supernatant in vitro. These experiments, together with our results showing that CsA decreases the amount of LFNDTA found in the cytosol of LFNDTA/PA-treated cells (Fig. 3 ), favour a model in which CsA inhibits PA-mediated translocation across the endosomal membrane, rather than a subsequent step, such as refolding.
An antibody against CypA inhibits in vitro translocation of LF NDTA from enriched endosomal vesicles
CsA inhibits the PPIase activity of various Cyps. Therefore, to determine the particular host cell Cyp that facilitates membrane translocation of LFNDTA, we pretreated the cytosol with a specific antibody against CypA, the most prominent cytosolic Cyp and the major target of CsA in mammalian cells, before adding the cytosol to the LFNDTA-containing endosomal vesicles to induce translocation. As a control, untreated cytosol was used. The in vitro translocation assay was performed as described above. Equal protein loading was confirmed by MEK-1 immunoblot analysis (not shown). As shown in Fig. 4C , there was only negligible ADP-ribosylation of EF-2 when LFNDTA-containing vesicles were incubated with cytosol pretreated with anti-CypA. Importantly, the anti-CypA antibody had no influence on the ADP-ribosyltransferase activity of LFNDTA as tested in a cell free system in vitro (Fig. 4D ). In conclusion, these results indicate that CypA is the relevant Cyp that facilitates membrane translocation of LFNDTA in vitro.
Rad has an inhibitory effect on the PA-mediated uptake of active LFNDTA from endosomal vesicles and protects CHO-K1 cells from intoxication by LFNDTA/PA
Finally, we investigated whether Hsp90 is also involved in PA-mediated uptake of LFNDTA. LFNDTA preloaded endosomal vesicles were incubated with cytosol to induce in vitro translocation of LFNDTA. The cytosol was treated for 30 min with or without Rad, an inhibitor of Hsp90, before addition to the endosomal vesicles. As shown in Fig. 5A and B, less EF-2 was ADP-ribosylated by LFNDTA when the cytosol was pretreated with Rad. However, Rad had no effect on the ADP-ribosyltransferase activity of LFNDTA (Fig. 5C ). These findings strongly suggest that Hsp90 activity is crucial for the PA-mediated uptake of active LFNDTA from endosomal vesicles in vitro.
Prompted by this finding, we tested whether inhibition of Hsp90 protects CHO-K1 cells from intoxication by LFNDTA/PA. Cells were pretreated with or without Rad, then LFNDTA and PA were applied, and the toxincatalysed inactivation of cytosolic EF-2 was measured by incorporation of [ 14 C]-leucine into the cellular proteins (Fig. 5D ). In the absence of Rad there was strongly decreased incorporation of [ 14 C]-leucine, indicating inhibition of protein biosynthesis as a result of LFNDTAmediated inhibition of EF-2. In contrast, in Rad-treated cells, there was no significant inhibition of protein biosynthesis by LFNDTA. Moreover, in the presence of Rad, less biotin-LFNDTA protein was detected in the digitonin extracted cytosolic fractions of LFNDTA/PA-treated CHO-K1 cells compared with cells that were not pre-
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treated with Rad before toxin application (data not shown). In line with these results, pretreatment of Vero cells with Rad partially inhibited the LFNDTA-catalysed ADP-ribosylation of EF-2 in the cytosol of cells treated with LFNDTA + PA (data not shown). Thus, the observed effects are not restricted to a single cell line. In combination with the result from the in vitro uptake assay, the data strongly suggest that Rad inhibits the release of active LFNDTA from endosomes to the cytosol, implying that Hsp90 likely facilitates PA-mediated translocation or a subsequent step (e.g. refolding) of LFNDTA in mammalian target cells.
LFNDTA directly interacts with Hsp90 and CypA in vitro
To investigate whether LFNDTA interacts with CypA or Hsp90 in vitro, we analysed binding of biotinylated LFNDTA and LF proteins to immobilized CypA and Hsp90 in a dot-blot assay. Importantly, LFNDTA showed specific and concentration dependent binding to both proteins. In contrast, there was no interaction between LF and CypA or Hsp90 (Fig. 6A) . Thus, the DTA portion of LFNDTA likely mediates binding of this protein to CypA and Hsp90 and therefore we performed this binding assay with biotinylated DTA proteins. As shown in Fig. 6B , there was a specific and concentration dependent binding of both wild-type DTA and DTA-E148S, which lacks ADPribosyltransferase activity, to the immobilized CypA and Hsp90 proteins. However, the lack of interaction between LF and CypA or Hsp90 in vitro is an indication that PA-mediated uptake of LF into the cytosol of target cells might be independent of these host cell factors.
CypA and Rad do not protect cells from intoxication by LF
Prompted by the observation that both CypA and Hsp90 interact with LF NDTA but not with LF in vitro, we addressed whether inhibition of these host cell factors has an effect on the intoxication of cells by anthrax lethal toxin (LeTx = PA + LF). In a first approach, we tested the influence of CsA and Rad on the LeTx-induced cell death of cultured macrophages. J774A.1 cells were pretreated with the inhibitors alone and in combination, challenged with LeTx, and the viability of the cells was determined by MTS assay. As shown in Fig. 7A , neither CsA nor Rad nor the combination of both had a significant inhibitory effect on the cytotoxic action of the toxin, implying that Cyps and Hsp90 are not necessary for uptake of LF into the cytosol of the macrophages. In line with this result, there was no inhibitory effect of CsA or Rad on the LF-catalysed cleavage of MEK1 in CHO-K1 fibroblasts and Vero epithelial cells as demonstrated in Fig. 7B and C respectively. Taken all together, our results indicate that CsA and Rad inhibit the PA-mediated transport of LF NDTA but not of LF into the cytosol of mammalian target cells, strongly suggesting that the DTA domain of the fusion toxin is responsible for interaction with both host cell factors.
Discussion
It has become evident that cytosolic host cell factors are required for the intracellular membrane translocation of certain bacterial protein toxins, including diphtheria toxin (DT) (Ratts et al., 2003) , anthrax lethal toxin (Tamayo et al., 2008) and the binary actin ADP-ribosylating C2 toxins from clostridia (Haug et al., 2003a; Kaiser et al., 2009) . The chaperone activity of the heat shock protein Hsp90 facilitates translocation of the catalytic subunits of DT (DTA) (Ratts et al., 2003) and C2 toxin (C2I) (Haug et al., 2003a) from the lumen of acidified endosomes to the cytosol. In addition to Hsp90, thioredoxin reductase and b-COP from the COPI coatomer complex are required for the productive membrane translocation of DTA (Ratts et al., 2003) . Interestingly, the conserved peptide motif T1 within the DT transmembrane helix 1, which mediates the interaction with b-COP (Ratts et al., 2003) , was also identified in anthrax LF and EF as well as in the neurotoxins from Clostridium botulinum BoNTs A, C, D (Ratts et al., 2005) . So far, no host cell chaperones are known for the BoNTs but it was reported that the heavy chain of BoNT/A, which forms a pore in endosomal membranes to achieve translocation of the enzymatically active light chain, serves as an intramolecular chaperone for the latter Fig. 4 . CsA as well as an antibody against CypA have inhibitory effects on translocation of LFNDTA from the lumen of endosomal vesicles into the cytosol in vitro. PA63/LFNDTA-loaded endosomal vesicles were purified by sucrose density gradient centrifugation from CHO-K1 cells, previously treated with PA83 (10 nM) + LFNDTA (10 nM) in the presence of Baf A1. A. Enriched toxin-containing endosomes were subjected to in vitro translocation assay by incubating 5 ml of vesicles together with freshly prepared cytosol from CHO-K1 cells (40 mg of protein) in 20 ml translocation buffer containing biotin-NAD + (10 mM) for 30 min at 37°C. For control, toxin-containing vesicles were incubated with translocation buffer instead of cytosol. Vesicles were pelleted and the supernatant was then incubated with cytosol containing biotin-NAD + as described before. Proteins were separated by SDS-PAGE, blotted and the biotin-labelled, i.e. ADP-ribosylated, EF-2 was detected with streptavidin-peroxidase. B. To test the influence of CsA on translocation of LFNDTA from endosomal vesicles, cytosol was pre-incubated for 30 min at 37°C with 20 mM CsA before application to the vesicles. Thereafter, vesicles were pelleted by ultracentrifugation, the cytosolic supernatant was subjected to SDS-PAGE, blotted and the biotin-labelled, i.e. ADP-ribosylated, EF-2 was detected with streptavidin-peroxidase (upper panel). Comparable protein loading was confirmed by anti-MEK1 immunoblot analysis (lower panel). Intensity of the biotin-labelled EF-2 bands was determined by densitometry and is given as mean Ϯ SD (n = 3). Significance was tested by using the student's t-test (*P < 0.05).
C. An antibody against CypA prevents translocation of LFNDTA from early endosomes into the cytosol in vitro. PA63/LFNDTA-loaded endosomal vesicles from CHO-K1 cells were incubated for 30 min at 37°C together with freshly prepared CHO-K1 cytosol (40 mg of protein) in 20 ml translocation buffer containing biotin-NAD + (10 mM). In parallel, cytosol that was pre-incubated for 30 min at 37°C with 4 ml of anti-CypA was applied to endosomal vesicles in this assay. Thereafter, the endosomes were pelleted by ultracentrifugation, the cytosolic supernatant was subjected to SDS-PAGE, blotted and the biotin-labelled, i.e. ADP-ribosylated, EF-2 was detected with streptavidin-peroxidase. Intensity of the biotin-labelled EF-2 band was determined by densitometry and is given as mean Ϯ SD (n = 3). Significance was tested by using the student's t-test (***P < 0.0005). Equal protein loading was confirmed with a MEK1-specific antibody (not shown). D. Anti-CypA has no influence on the enzyme activity of LFNDTA. Lysate from CHO-K1 cells was pre-incubated for 30 min at 37°C with anti-CypA antibody (2 ml in 10 ml of lysate). For control, lysate was left untreated. LFNDTA (1 nM) and 10 mM biotin-NAD + were added and samples were incubated for 10 min at 37°C. Proteins were separated by SDS-PAGE, blotted and ADP-ribosylated EF-2 was detected with strepatavidin-peroxidase. Intensity of the biotin-labelled EF-2 band was determined by densitometry and is given as mean Ϯ SD (n = 3). Significance was tested by using the student's t-test (NS = not significant). Equal protein loading was confirmed with a MEK1-specific antibody (not shown). (Brunger et al., 2007; Montal, 2010) . The N-terminal domain of anthrax LF (LFN) interacts with COPI coatomer complex proteins and thus Tamayo and co-workers concluded that the facilitated delivery of LFNDTA into the cytosol of target cells is likely analogous to that of DT entry (Tamayo et al., 2008) . However, it is not clear whether chaperones, for instance Hsp90, are also involved in membrane translocation of LFNDTA.
In the present study, we have performed a series of experiments to investigate whether Hsp90 and Cyps are required for PA-mediated delivery of active LFNDTA and LF in vitro and during uptake into mammalian cells. By using the specific pharmacological inhibitors Rad and CsA, we found that Hsp90 as well as Cyps participate in uptake of LFNDTA into the host cell cytosol and protected cells from intoxication by LFNDTA/PA. The data obtained C from both an in vitro translocation assay with partially purified endosomal vesicles and a cellular intoxication assay clearly revealed that CypA is necessary for efficient translocation of LFNDTA from the endosome to the cytosol. Similarly, we show that Hsp90 is required for PA-mediated uptake of active LFNDTA, and our results indicate that the chaperone is likely involved in either translocation from the endosome or a subsequent step such as refolding. Importantly, we excluded that CsA or Rad interfered with other steps of toxin action, such as receptor binding, endocytosis or modification of EF-2. These findings are in line with our recent observation that Hsp90 and CypA facilitate membrane translocation of C2I, the enzyme component of the binary actin ADPribosylating C. botulinum C2 toxin (Kaiser et al., 2009) . It is widely accepted that the binary C2 and the anthrax toxins share an overall comparable mechanism to deliver their enzyme components into the cytosol of target cells [for review see (Barth et al., 2004) ]. Similar to PA 63, the binding and translocation component from C2 toxin, C2IIa, forms ring-shaped heptamers (prepores), which share high structural homology with PA63. First, C2IIa mediates binding of C2I to the cell surface and later, during uptake, the release of C2I from acidified early endosomes. To this end, C2IIa forms pores with an inner diameter of~1-2 nm that insert into the endosomal membrane; unfolded C2I translocates in a pH-dependent manner through these pores to the cytosol (Barth et al., 2000; Blöcker et al., 2003a,b; Haug et al., 2003b) . We have recently demonstrated the essential role of Hsp90 and CypA during uptake of C2I into the host cell cytosol, showing a direct and specific interaction between C2I and both host cell proteins in vitro and in intact cells (Haug et al., 2003a; Kaiser et al., 2009 ). Although we detected binding of Hsp90 and CypA to the N-terminal adaptor domain of C2I (C2IN) (Kaiser et al., 2009) , these proteins might also interact with the C-terminal ADPribosyltransferase domain of C2I as the crystal structure of C2I revealed very similar folding and overall structures of its N-and the C-terminal domains (Schleberger et al., 2006) . Taken all together, our data suggest that Hsp90 and CypA may facilitate toxin-mediated delivery of C2I and LF NDTA through analogous mechanisms.
In the light of our results obtained for LFNDTA, the observation that the PA-mediated uptake of LF into the cytosol was not influenced by Rad or CsA is remarkable. However, it is consistent with our earlier observations (Haug et al., 2003a) and with a recent report by Zornetta et al. demonstrating by confocal microscopy that the combination of both inhibitors did not block the delivery of fluorescent LF or EF proteins into the cytosol of BHK cells (Zornetta et al., 2010) . Because LFN mediates the interaction of both LF and LFNDTA with PA63, a comparable mechanism for the PA-dependent translocation of both proteins into the cytosol should be expected. Moreover, Tamayo et al. demonstrated that LFNDTA requires COPI coatomer complex for membrane translocation and that the LFN domain interacts with the components of this complex, such as z-COP and b-COP (Tamayo et al., 2008) . Therefore, we expected that the interaction of LFNDTA with Hsp90 and CypA would also occur via the LFN moiety and therefore should be comparable for LFNDTA and LF. In contrast, our results clearly demonstrated that in vitro Hsp90 and CypA directly interact with DTA, the ADPribosyltransferase domain of the LFNDTA fusion toxin, a plausible explanation for the finding that inhibition of these Fig. 5 . Rad has an inhibitory effect on the in vitro translocation of LFNDTA from endosomal vesicles into the cytosol and protects CHO-K1 cells from intoxication by LFNDTA/PA. A. Effect of Rad on membrane translocation of LFNDTA in vitro. PA63/LFNDTA-loaded endosomal vesicles were purified by sucrose density gradient centrifugation from CHO-K1 cells, previously treated with PA83 (10 nM) + LFNDTA (10 nM) in the presence of Baf A1. After gradient centrifugation aliquots (5 ml) of the PA83 + LFNDTA-loaded endosomal vesicles (indicated as EE) were incubated for 30 min at 37°C together with freshly prepared CHO-K1 cytosol (40 mg of protein) in 20 ml translocation buffer containing biotin-NAD + (10 mM). To test the influence of Rad on translocation of LFNDTA, freshly prepared cytosol was incubated for 30 min at 37°C together with 20 mM Rad before application upon the toxin-containing endosomes. Thereafter, the endosomes were collected as pellets by ultracentrifugation, the cytosolic supernatant was subjected to SDS-PAGE, blotted and the biotin-labelled, i.e. ADP-ribosylated, EF-2 (ADP-rib. EF-2 = ADP-ribosylated EF-2) was detected by using streptavidin-peroxidase and the ECL system. Equal amounts of protein from the cytosolic fractions were confirmed by immunoblot analysis with an anti-MEK1 antibody (lower panel). B. The intensity of the biotin-labelled EF-2 band was determined by densitometry and is given as mean Ϯ SD (n = 3). Significance was tested by using the student's t-test (**P < 0.005). C. Rad has no effect on the ADP-ribosyltransferase activity of LFNDTA in vitro. Lysate from CHO-K1 cells was pre-incubated for 30 min at 37°C with 10 mM Rad or left untreated for control. After that, LFNDTA (1 nM) and biotin-NAD + (10 mM) were added and samples were incubated for 10 min at 37°C. Proteins were separated by SDS-PAGE, blotted and ADP-ribosylated EF-2 was detected with strepatavidin-peroxidase. Intensity of the biotin-labelled EF-2 band was determined by densitometry and is given as mean Ϯ SD (n = 3). Significance was tested by using the student's t-test (NS = not significant). Equal protein loading was confirmed with a MEK1-specific antibody (not shown). D. Rad protects CHO-K1 cells from intoxication by LFNDTA/PA. CHO-K1 cells were pretreated for 1 h at 37°C with or without Rad (1 mM) at 37°C. Cells were further incubated with PA63 (6.4 nM) plus LFNDTA (3.7 nM) for 2 h at 37°C. Afterwards, the medium was replaced by L-leucine-free medium supplemented with [ host cell proteins does not affect PA-mediated uptake of LF. This is also in line with our observation that LFNDTA, but not LF, directly interacts with Hsp90 and CypA in vitro.
Moreover, the findings that LFN does not interact with Hsp90 but does interact with components of the COPI coatomer complex are a hint that during PA-mediated membrane translocation these factors might bind to separate domains of the LFNDTA protein. Taken together, the results reported here and earlier work suggest that PA-mediated delivery of LF depends on COPI coatomer complex proteins, but not on Hsp90 or CypA, while delivery of LFNDTA requires both Hsp90 and CypA in addition to COPI coatomer complex. Inhibition of Hsp90 and CypA activity likely prevents proper folding of the DTA domain and may affect release of the protein into the cytosol. In contrast, the enzyme domain of LF seems to refold independent of these factors. However, at present we cannot exclude the involvement of other chaperones or PPIases in the PA-mediated delivery of LF. Thus, we conclude that the enzyme domain of the cargo protein, and not the LF N domain or the translocation pore, is responsible for the interaction with Hsp90 and CypA during toxin-mediated delivery.
From this perspective, it is interesting that all bacterial toxins that have been found to interact with either Hsp90 or PPIases thus far are mono-ADP-ribosyltransferases, which deliver their catalytic domain from acidified endosomes to the cytosol. Besides DT, PA/LFNDTA and C2 toxin, other bacterial ADP-ribosylating toxins that require Hsp90 and Cyps for membrane translocation are the Clostridium perfringens iota toxin and the Clostridium difficile transferase CDT (Kaiser et al., in preparation) , strongly implying a common chaperone/PPIasedependent translocation mechanism for the family of binary ADP-ribosylating toxins. Moreover, C2 fusion toxins were also sensitive to CsA and Rad when the catalytic domain of C2I was replaced by a foreign ADP-ribosyltransferase domain, for instance the Rhoinactivating C3 protein from Clostridium limosum or the catalytic actin-ADP-ribosylating C/SpvB domain of Salmonella enterica (Haug et al., 2003a; Pust et al., 2007) .
Bacterial mono-ADP-ribosyltransferases show a highly conserved overall folding of their catalytic cores (Collier, 1995; Galan, 1998; Masignani et al., 2000) . Therefore refolding of these domains following translocation across intracellular membranes might be facilitated by Hsp90/CypA and thus could explain why ADPribosyltransferases require the assistance of these host cell factors during uptake into the host cell cytosol. Future experiments with new toxin chimeras will be helpful to verify this hypothesis and to characterize the molecular interaction between bacterial ADP-ribosyltransferases and host cell factors in more detail.
Finally, it will be interesting to investigate whether Hsp90 and Cyps also facilitate membrane translocation of bacterial ADP-ribosylating toxins that deliver their enzyme domains to the host cell cytosol by mechanisms other than translocation from acidified endosomes. Such examples are the ADP-ribosyltransferase SpvB from S. enterica (Lesnick and Guiney, 2001 ) and exoenzyme S from Pseudomonas aeruginosa, which are delivered by intracellularly located bacteria into the cytosol of host cells (Barbieri and Frank, 2002) or cholera toxin, which delivers its ADP-ribosyltransferase moiety from the endoplasmic reticulum into the cytosol (Majoul et al., 1996) . Interestingly, the catalytic domain of the plant toxin ricin, which were vacuum aspirated onto a nitrocellulose membrane using a dot-blot system. For control, PBS was aspirated instead of protein.
The membrane was blocked with 5% non-fat dry milk in PBS-T and subsequently incubated with either biotinylated LFNDTA (upper panel), biotinylated LF (mid panel, each protein 200 ng ml -1 in PBS) or for control with PBS (lower panel). Subsequently, membranes were washed three times with PBS-T followed by incubation with streptavidin-peroxidase to detect bound biotinylated LFNDTA or LF proteins by the ECL system. B. DTA directly interacts with both Hsp90 and CypA in vitro. Hsp90 and CypA were spotted onto a membrane and the membrane was blocked exactly as described in A. Subsequently, the membrane was incubated with biotinylated wild-type DTA (upper panel) and biotinylated DTA-E148S (mid panel, each protein 200 ng ml -1 in PBS). The bound DTA proteins were detected as described in A.
translocates as an unfolded protein from the endoplasmic reticulum to the cytosol, also interacts with cytosolic host cell chaperones Hsc70 and Hsp90, which likely refold plant toxin ricin after translocation and prevent its degradation and aggregation (Spooner et al., 2008) .
Taken all together, we have demonstrated that, although the LFNDTA fusion toxin and LF bind to PA via the same domain and only differ in their C-terminal catalytic domains, LFNDTA requires Hsp90 and CypA for PA-mediated delivery into the host cell cytosol, while LF does not require these factors. Moreover, we provided evidence that DTA directly interacts with both Hsp90 and CypA in vitro. The ADP-ribosyltransferase activity of DTA is not required for this interaction, as wild-type DTA and DTA-E148S, which lacks the active-site residue glutamic acid-148 and shows drastically reduced (~300-fold) ADPribosyltransferase activity (Wilson et al., 1990) bound to immobilized CypA and Hsp90 proteins, too. These findings, along with results reported elsewhere, suggest that the ADP-ribosyltransferase domains of bacterial toxins recruit Hsp90 and/or PPIases to facilitate their membrane translocation and/or refolding during uptake into the cytosol. Overall, our findings strongly suggest that the catalytic domains of bacterial toxins are of greater importance than previously recognized in the recruitment of host cell factors necessary for efficient cellular uptake.
Experimental procedures
Materials
Cell culture media DMEM and fetal calf serum were obtained from Invitrogen (Karlsruhe, Germany) and HAM's F12 from Gibco (Karlsruhe, Germany). Cell culture materials were obtained from TPP (Trasadingen, Switzerland). Complete ® protease inhibitor was purchased from Roche (Mannheim, Germany). The protein molecular weight marker Page Ruler prestained Protein ladder ® Fig. 7 . CsA and Rad do not inhibit the cytotoxic effects of the anthrax lethal toxin (LeTx) in CHO-K1, J774A.1 and Vero cells. A. J774A.1 macrophages were pretreated for 30 min with either CsA (10 mM) or Rad (1 mM) or with the combination of both inhibitors. For control, cells were left untreated (con). Subsequently PA83 (3.6 nM) + LF (3.3 nM) were added, the cells were further incubated at 37°C in the presence of the toxin and the inhibitors and the viability was measured after 3 h by MTS assay. Data are given as mean Ϯ SD (n = 3). Significance was tested by using the student's t-test (**P < 0.005, NS = not significant). B. Effect of CsA and Rad on the LF-catalysed cleavage of MEK1 in the cytosol of CHO-K1 cells. Cells were pretreated for 30 min with either CsA (10 mM) or Rad (10 mM) or with the combination of both inhibitors. For control, cells were left untreated. As a further control, cells were treated with Baf A1 (100 nM) to inhibit endosomal acidification. PA83 (1.2 nM) + LF (1.1 nM) were applied and cells were incubated for 3 h at 37°C, lysed and equal amounts of protein were subjected to SDS-PAGE. Immunoblot analysis was performed with an antibody against the N-terminal peptide of MEK1, which is removed by LF from the MEK1 protein (upper panel) and with an antibody raised against the unmodified C-terminal part of MEK1 (lower panel). C. Effect of CsA and Rad on the LF-catalysed cleavage of MEK1 in the cytosol of Vero cells. Vero cells were pretreated for 30 min with CsA (10 mM) or Rad (10 mM). Cells were incubated for 1.5 and 2.5 h with PA83 (1.2 nM) + LF (1.1 nM). Cells were lysed and MEK1 cleavage was analysed exactly as described in B (Western blot shown for the 2.5 h values). The intensity of the uncleaved MEK1 bands was determined by densitometry. 
Purification and biotinylation of proteins
CypA was purified as described (Fanghänel and Fischer, 2003) . Human Hsp90b was purified as described . Anthrax proteins and fusion toxin LFNDTA were expressed and purified as described (Wesche et al., 1998) . DTA-E148S construct was generated by mutating residue 148 of DTA using QuikChange Site-Directed Mutagenesis kit (Stratagene, La Jolla, CA, USA). Both, DTA and DTA-E148S genes, were then PCR amplified and cloned into pET-SUMO vector (Invitrogen) using the manufacturer provided protocol so that an in frame SUMO-DTA fusion protein is produced. The E. coli BL21(DE3) strain was used as the host strain for expression of the recombinant proteins. Overexpressed SUMO-DTA fusion proteins were purified using a nickel-chelating agarose column and then cleaved with SUMO protease. Subsequently, the recombinant DTA proteins were separated from SUMO and SUMO protease using a nickel-chelating agarose column. The biotinylation of LFNDTA, LF, DTA and DTA-E148S was performed with sulfo-NHS-biotin (Pierce, Rockford, Illinois, USA) according to the manufacturer's instructions.
Cell culture and intoxication assays
CHO-K1 (Chinese hamster ovary) cells were cultivated in DMEM and HAM's F12 containing 5% heat-inactivated fetal calf serum, 1 mM sodium-pyruvate and Penicillin-Streptomycin (1:100). J774A.1 macrophage-like cells were cultivated at 37°C and 5% CO2 in Dulbecco's modified Eagle medium (DMEM), containing 10% heat-inactivated fetal calf serum, L-glutamate (4 mM), penicillin (100 U ml -1 ) and streptomycin (100 mg ml -1 ). Vero (African green monkey kidney) cells were cultivated in MEM containing 10% heat-inactivated fetal calf serum, 1.5 g l -1 sodium bicarbonate, 1 mM sodium-pyruvate, 2 mM L glutamine and 0.1 mM nonessential amino acids. The cell lines were cultivated at 37°C and 5% CO2. Cells were trypsinized and reseeded for at most 15-20 times. For intoxication experiments, cells were seeded in culture dishes and for inhibition of the PPIase activity of Cyps, the cells were pre-incubated for 30 min with 20 mM CsA. Control cells were incubated without any inhibitor. Subsequently, the indicated concentrations of PA63 + LFNDTA were added and cells were further incubated at 37°C with toxin plus inhibitor. After the given incubation periods the cells were lysed, followed by an incubation with LFNDTA (1 nM) and biotin-labelled NAD + (10 mM) for 30 min at 37°C for an in vitro ADP-ribosylation of the EF-2, which is not yet ADP-ribosylated by the toxin. Samples were subjected to SDS-PAGE, blotted and ADP-ribosylation status of EF-2 was analysed. Equal amounts of protein were confirmed by immunoblot analysis with an anti-b-actin antibody. Intensity of ADPribosylated EF-2 was determined by densitometry using the Adobe Photoshop 7.0 software. To determine the cytotoxic effects of lethal toxin, J774A.1 macrophages were pretreated with PA63 + LF at 37°C and the viability was measured by Cell Titer 96 ® Aqueous One Solution cell proliferation assay (MTS assay) (Promega, Mannheim, Germany) according to the manufacturer's instructions. Alternatively, the LF-catalysed cleavage of MEK1 in the cytosol of CHO-K1 and Vero cells was detected by immunoblot analysis with an antibody raised against MEK1 (Nanotools, Teningen, Germany).
Measurement of protein biosynthesis by incorporation of radioactively labelled amino acids
Rad studies. CHO-K1 cells were pretreated with or without 1 mM Rad for 1 h at 37°C. Cells were further incubated with the indicated concentrations of PA63 + LFNDTA for 2 h at 37°C. Afterwards, the medium was replaced with L-leucine-free medium supplemented with [
14 C]-leucine to monitor protein synthesis. After 1 h incubation at 37°C, cells were washed three times with cold PBS and lysed by 0.1% SDS. Proteins were precipitated by 10% trichloroacetic acid and the amount of incorporated [
14 C]-leucine was measured by filter assay and liquid scintillation counting.
CsA studies. CHO-K1 cells were incubated with or without 1 M CsA for 30 min at 37°C, after which time PA83 and LFNDTA were each added to a final concentration of 10 nM. As a control, buffer alone was added. Cells were allowed to incubate for an additional 4 h at 37°C. At this time, the buffer was removed and replaced with leucine-free media supplemented with [ 3 H]-leucine. Cells were incubated for an additional 1 h at 37°C, at which time the media was removed, cells were washed twice with PBS and trypsin was added to lift the cells from the plate. Cells were transferred to vials containing scintillation fluid, and the radioactivity was measured using scintillation counting.
ADP-ribosylation of EF-2 by LFNDTA in a cell-free system
CHO-K1 lysate (30 mg of protein) was incubated for 30 min at 37°C with 20 mM CsA or 10 mM Rad or anti-CypA antibody (2 ml). As a control, cell lysate was incubated with buffer only. After 30 min, a final concentration of 1 nM LFNDTA was added together with 10 mM biotin-labelled NAD + and incubated for 10 min at 37°C. Samples were subjected to SDS-PAGE and blotted onto a nitrocellulose membrane. ADP-ribosylated, i.e. biotin-labelled, EF-2 was detected with streptavidin-peroxidase.
Detection of LFNDTA in the cytosolic fractions of CHO-K1 cells
The cytosolic fraction from cultured CHO-K1 cells was obtained by treatment of cells with digitonin according to the method originally described by Wiedlocha et al. (Wiedlocha et al., 2005; Kaiser et al., 2009) . CHO-K1 cells, grown in 12-well plates, were pre-incubated at 37°C with CsA (20 mM) for 30 min. Control cells were incubated without any inhibitor. Subsequently, the indicated amounts of PA63 and biotin-labelled LFNDTA were applied to cells, which were incubated for an additional 1.5 h with toxin and the inhibitors. For a control, cells were incubated without PA63 and LFNDTA. Afterwards, cells were washed twice with ice-cold PBS to remove unbound toxin from the surface, then they were incubated for 5 min at 25°C in the presence of digitonin (20 mg ml -1 in PBS) to permeabilize the cell membrane and for an additional 30 min at 4°C to allow extraction of the cytosolic proteins, including biotin-labelled LFNDTA. The supernatant was collected, equal amounts of protein were subjected to SDS-PAGE and biotin-labelled LFNDTA was detected with streptavidinperoxidase using the ECL system. To confirm equal amounts of protein, immunoblot analysis with antibodies raised against MEK1 was performed. The absence of early endosomes in the cytosolic fraction was confirmed in an immunoblot with an antibody raised against EEA1, a marker protein for early endosomes. Intensity of the biotin-labelled LFNDTA was determined by densitometry using the Adobe Photoshop 7.0 software.
In vitro translocation of LFNDTA from enriched endosomal vesicles
The partial purification of toxin-preloaded endosomal vesicles was performed according to a modified flotation protocol from Lemichez et al. (Lemichez et al., 1997) . In brief, CHO-K1 cells were seeded on 10 cm culture dishes. Cells were carefully scraped off from 30 dishes, collected and incubated in 6 ml cell culture medium for 2 h with PA83 (10 nM) plus LFNDTA (10 nM) in the presence of Baf A1 (100 nM). Then the toxin-containing medium was removed and fresh toxin-free medium containing Baf A1 was added to the cells for an additional hour. Cells were washed and resuspended in 1 ml 11.4% sucrose buffer and discontinuous sucrose density gradient ultracentrifugation was performed with a TH461 rotor at 31 000 r.p.m. for 2 h at 4°C. The phase containing early endosomes was collected as a pellet by ultracentrifugation (70 000 r.p.m., 20 min, 4°C). The pellet was resuspended in 100 ml translocation buffer (100 mM Tris-HCl pH 7.4, 25 mM EDTA, complete protease inhibitor, 5 mM ATP and 5 mM MgCl2).
Translocation of LFNDTA from the enriched endosomal vesicles was performed according to the method of Tamayo et al. (Tamayo et al., 2008) with modifications. Toxin-loaded endosomes (5 ml) were incubated for 30 min at 37°C together with freshly prepared CHO-K1 cytosol (40 mg of protein) in 20 ml translocation buffer containing biotin-NAD + (10 mM). To test the influence of Cyps or Hsp90 on the translocation of LFNDTA from the endosomal vesicles into the cytosol, aliquots from the cytosol were incubated for 30 min at 37°C together with 20 mM CsA or 20 mM Rad before application upon the toxin-containing endosomal vesicles. To confirm the influence of CypA on the translocation of LFNDTA, the cytosol was incubated for 30 min at 37°C together with 4 ml of anti-CypA antibody (Calbiochem) before addition of the cytosol to toxin-containing endosomes. Thereafter, the supernatant (cytosol) and the pellet fraction (endosomal vesicles) were separated by ultracentrifugation (70 000 r.p.m., 20 min, 4°C). The cytosolic supernatant containing biotinlabelled, ADP-ribosylated, EF-2 was subjected to SDS-PAGE and biotin-labelled EF-2 was detected on a nitrocellulose membrane using streptavidin-peroxidase and the ECL system.
As controls, heat-inactivated cytosol (30 min 95°C) and translocation buffer (without cytosol and without biotin-NAD + ) were applied to the endosomes. In these samples the endosomes were collected as pellets after an incubation of 30 min at 37°C by ultracentrifugation (70 000 r.p.m., 20 min, 4°C). The supernatant was subsequently incubated with fresh CHO-K1 lysate plus biotin-NAD + (30 min, 37°C), and subjected to SDS-PAGE and subsequent immunoblot analysis. The biotin-labelled EF-2 was detected by using streptavidin-peroxidase and the ECL system. Equal amounts of protein from the cytosolic fractions were confirmed by immunoblot analysis with an anti-MEK1 antibody. Intensity of the biotin-labelled LFNDTA was determined by densitometry using the Adobe Photoshop 7.0 software.
SDS-PAGE and immunoblot analysis.
For immunoblot analysis, equal amounts of protein were subjected to SDS-PAGE according to the method of Laemmli (Laemmli, 1970) . Subsequently, the proteins were transferred to a nitrocellulose membrane (Whatman, Dassel, Germany). The membrane was blocked for 30 min with 5% non-fat dry milk in PBS containing 0.1% Tween-20 (PBS-T). For the detection of the different biotinlabelled substrate molecules (LFNDTA or EF-2), the samples were probed with streptavidin-peroxidase. Subsequently, the membrane was washed and proteins visualized using a chemiluminescence (ECL) system according to the manufacturer's instructions. For the detection of actin as a loading-control, the samples were probed with a mouse monoclonal anti-b-actin antibody (clone AC-15; Sigma-Aldrich). After washing with PBS-T, the membrane was incubated for 1 h with an anti-mouse antibody coupled to horseradish-peroxidase (Santa Cruz Biotechnology, Heidelberg, Germany). The membrane was washed and the proteins visualized in a subsequent chemiluminescence reaction. For detection of cleaved MEK1, an antibody from Santa Cruz Biotechnology was taken. Uncleaved MEK1 was detected using a monoclonal antibody from Nanotools.
Dot-blot analysis of the interaction between immobilized Hsp90
and CypA with LFNDTA. Different amounts of Hsp90 and CypA were vacuum aspirated onto a nitrocellulose membrane using a dot-blot system (Bio-Rad, Munich, Germany) according to the manufacturer's instructions. Subsequently the membrane was blocked for 1 h with 5% non-fat dry milk in PBS containing 0.1% Tween-20 (PBS-T). The membrane was incubated with the biotinylated proteins LFNDTA, LF, DTA and DTA-E148S (200 ng ml -1 each), washed three times with PBS-T (5 min each) and the bound biotinylated proteins were detected with streptavidinperoxidase using the ECL system.
Reproducibility of the experiments and statistics.
All experiments were performed independently at least two times. Results from representative experiments are shown in the figures. In each individual immunoblot panel shown in the figures, the protein bands were originally detected on the same membrane and only cut out and recombined for presentation in the figures. Values (n Ն 3) are calculated as mean Ϯ standard deviation (SD) using the Prism4 Software (GraphPad Software, La Jolla, CA, USA).
